Jose M. Navarro-Fernandez

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

Journal: Trials

Published: February 13, 2026

Spanish Paediatric Haematology and Oncology Survival Results and Trends, 1999-2022.

Spanish Paediatric Haematology and Oncology Survival Results and Trends, 1999-2022.

Journal: Cancers

Published: December 29, 2025

Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease.

Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 11, 2024

Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).

Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).

Journal: Transplantation and cellular therapy

Published: January 18, 2024

Hematopoietic stem cell transplantation in children with chronic granulomatous disease: the Spanish experience.

Hematopoietic stem cell transplantation in children with chronic granulomatous disease: the Spanish experience.

Journal: Frontiers in immunology

Published: October 05, 2023

Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.

Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.

Journal: Blood advances

Published: September 24, 2023

Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).

Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).

Journal: Transplantation and cellular therapy

Published: April 27, 2023

Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.

Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 30, 2023

Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortium.

Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortium.

Journal: Expert review of anticancer therapy

Published: October 03, 2022

Role of extracorporeal photopheresis in the management of children with graft-vs-host disease.

Role of extracorporeal photopheresis in the management of children with graft-vs-host disease.

Journal: Journal of clinical apheresis

Published: April 28, 2022

Casuistics of inflammatory myofibroblastic tumor in a tertiary center.

Casuistics of inflammatory myofibroblastic tumor in a tertiary center.

Journal: Anales de pediatria

Published: September 10, 2020

Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH).

Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH).

Journal: American journal of hematology

Published: June 28, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026